Updates

November 14, 2019November 14, 2019
Enrollment Completed for Phase 3 Trial Testing Provenge in Prostate Cancer Patients on Active Surveillance

Dendreon Pharmaceuticals has completed patient enrollment ahead of schedule in an ongoing Phase 3 trial assessing the safety and efficacy of its immunotherapy Provenge ... Read more
November 13, 2019
Phase 1 DRGT-45 Trial Doses First Patient With New Oral Formulation of Abiraterone Acetate

A Phase 1 clinical trial testing DRGT-45 — a new oral formulation of abiraterone acetate — in men with prostate cancer has dosed ... Read more
November 11, 2019
Men with BRCA2 Mutations Should Get Regular PSA Screening, Phase 3 Interim Data Suggest

Prostate-specific antigen (PSA) testing — a controversial approach to detecting prostate cancer — spotted the cancer more often, at a younger age, and in ... Read more
November 7, 2019November 11, 2019
Use of Assisted Reproduction Techniques Linked to Increased Prostate Cancer Risk, Study Suggests

Men who father children through assisted reproduction techniques, either in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), may be at a higher risk ... Read more
November 6, 2019
$1.8M NIH Award to Support Work into Robotic System Able to Better Detect Prostate Cancer

Haichong Zhang, an assistant professor at Worcester Polytechnic Institute, has been given a Director’s Early Independence Award from the National Institutes of Health (NIH) to ... Read more

News

Veru Completes Enrollment for Zuclomiphene Citrate Trial for ADT-Induced Hot Flashes in PC
November 4, 2019
Veru Healthcare has completed patient enrollment for its Phase 2 clinical trial evaluating the ...
News

Prostate Cancer Patients May Benefit from Routine Tumor Genetic Testing, Study Suggests
October 31, 2019
Implementation of routine tumor genetic testing may help identify the approximately 30% of men ...
News

Celebs in Parody Video Urge Support for Movember to Raise Prostate Cancer Awareness
October 30, 2019
In a lighthearted twist on a serious goal of raising awareness and funds for ...
News

Targeted Radiation (SBRT) Can Control Prostate Cancer That Has Spread Slightly, Trial Results Suggest
October 28, 2019
Stereotactic body radiation therapy (SBRT) — a form of targeted, high-dose radiation therapy — ...
News

Prostate Cancer Patients May Safely Skip Radiation Therapy After Surgery, Phase 3 Trial Shows
October 24, 2019October 25, 2019
Men with prostate cancer who undergo surgery have similar long-term outcomes whether they receive ...
News

FDA Grants Breakthrough Device Designation to IsoPSA Blood Test for Early Prostate Cancer Diagnosis
October 23, 2019
The U.S. Food and Drug Administration (FDA) has granted breakthrough device designation to Cleveland ...

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

Radiotherapy Plans Based on Machine Learning Being Used to Treat Localized PC Patients
October 21, 2019
Radiotherapy plans generated with machine learning in the RayStation system are now being used ...
Erleada-ADT Combo Increases Survival of mCSPC Patients Without Affecting Quality of Life, Phase 3 Trial Shows
October 17, 2019
Adding Erleada (apalutamide) to standard androgen deprivation therapy (ADT) increases the survival and delays ...
Long-term Hormone Therapy Does More Harm than Good in Prostate Cancer Patients with Low PSA Levels After Surgery, Analysis Shows
October 16, 2019October 25, 2019
Liproca Depot Shows Promise for Treatment of Early-Stage Prostate Cancer
October 14, 2019October 14, 2019
$35M Gift from Benioffs to Support Prostate Cancer Research Initiative at UCSF
October 10, 2019
Zejula Granted FDA’s Breakthrough Therapy Status for Treating Metastatic Castration-resistant Prostate Cancer
October 9, 2019

Jevtana Delays Disease Progression, Prolongs Survival in Men with mCRPC, Phase 4 Trial Shows
October 7, 2019
The chemotherapy agent Jevtana (cabazitaxel) is better than a second course of androgen receptor ...
Higher Radiation Therapy Doses Over Shorter Time Show No Added Side Effects in Men with Prostate Cancer, Study Says
October 3, 2019November 15, 2019
Erleada Cuts Risk of Death by 25% in Localized Castration-resistant Prostate Cancer, Phase 3 Trial Finds
October 2, 2019October 24, 2019
Focal Therapy, AuroLase, Shows Good Safety and Potential Effectiveness in Pilot Clinical Trial
September 30, 2019

Eating Mushrooms May Prevent Prostate Cancer, Japanese Study Suggests
September 26, 2019
Eating mushrooms frequently — three times a week or more — may have a ...
Prolaris Helps to ID Prostate Cancer Patients Suited for Active Surveillance, Study Says
September 23, 2019
FDA Approves Erleada to Treat Metastatic Castration-sensitive Prostate Cancer
September 19, 2019

News

Study Describes New Imaging Technique for Detecting Prostate Cancer
September 18, 2019
A new imaging technique that combines ultrasound and photoacoustic imaging of the prostate delivers ...
News

PSMA PET-CT Offers Better Detection Rates in Recurrent PC, Study Says
September 16, 2019
The imaging agent 68Ga-PSMA-11 has better detection rates than 18F-fluciclovine in men with recurrent ...
News

Landmarks Lit in Blue in Every US State to Launch Prostate Cancer Awareness Month
September 12, 2019
For the first time, landmarks in all 50 U.S. states were illuminated in blue ...
News

Largest-ever African American Prostate Cancer Study Seeks Participants
September 11, 2019
African American men recently diagnosed with prostate cancer are being recruited across the U.S. for ...
News

Provenge Extends Survival of mCRPC Patients By Up to 4 Years, Data Show
September 9, 2019September 24, 2019
Treatment with the immunotherapy Provenge (sipuleucel-T) in a real-world setting is showing similar safety ...
News

Collaborators Work to Develop New Sequencing Methods to Manage Cancers
September 5, 2019
The nonprofit organization Genome Canada, the pharmaceutical company Thermo Fisher Scientific and the Ontario ...
News

Add-on Onvansertib Overcomes Resistance to Zytiga in mCRPC, Early Data Show
September 4, 2019
Adding the investigational oral therapy onvansertib to a regimen of Zytiga (abiraterone acetate) and ...
News

FDA Clears Way for Trial of Immunotherapy in Advanced Prostate Cancer, Scripps Research Says
August 29, 2019
The U.S. Food and Drug Administration (FDA) has signed off on a clinical trial ...
News

Telix Enters Collaboration with DKFZ Researchers to Develop Image-Guided Surgery
August 28, 2019
Telix Pharmaceuticals has established a collaboration agreement with a team of researchers from the ...
News

Request for Xtandi to Treat Metastatic Hormone-sensitive Prostate Cancer Before FDA
August 26, 2019
The U.S. Food and Drug Administration (FDA) has agreed to review Astellas Pharma and ...
News

PSMA-targeted Therapies Work Best in Tumors with Mutations in DNA Repair Genes, Study Suggests
August 22, 2019
Tumors with large numbers of prostate cancer cells with mutations in DNA repair genes are ...
News

Myriad to Seek FDA Approval of Diagnostic Test to Determine Lynparza Eligibility for mCRPC Patients
August 21, 2019
Myriad Genetics is filing an application with the U.S. Food and Drug Administration requesting ...
News

Phase 1 Trial Enrolling Advanced, Castration-resistent Patients to Test Triple Immunotherapy Combo
August 19, 2019
A Phase 1 trial is enrolling people with metastatic castration-resistant prostate cancer (mCRPC) to test Inovio ...
News

Progenics Enters Collaboration with Veterans Affairs for Medical Image Analysis
August 14, 2019
Progenics Pharmaceuticals has entered a collaboration with Veteran Affairs Greater Los Angeles Healthcare System ...
News

Breast, Ovarian Cancer Therapy Seen to Delay to Progression in Advanced Prostate Cancers in Phase 3 Trial
August 12, 2019September 4, 2019
Men with metastatic castration-resistant prostate cancer (mCRPC) given Lynparza (olaparib), a breast and ovarian cancer ...
News

First Patients Dosed in Phase 2b Trial Testing Oral Docetaxel Treatment for Advanced Prostate Cancer
August 8, 2019September 10, 2019
A Phase 2b clinical trial evaluating ModraDoc006/r, Modra Pharmaceutical’s investigational oral treatment for metastatic castration-resistant ...
News

Prostate Cancer Therapy Zytiga Makes WHO’s Essential Medicines List
August 7, 2019August 26, 2019
Zytiga (abiraterone acetate), a kind of hormone therapy, has been added to the World ...
News

Xtandi Delays Disease Worsening in Metastatic Hormone-sensitive Prostate Cancer, Study Says
August 5, 2019
Adding Xtandi (enzalutamide) to androgen deprivation therapy (ADT) significantly delays disease progression or death in men ...

September 12, 2017September 12, 2017

Two High-Risk Prostate Cancer Treatments Have Similar Benefits, Add-On Study Finds

News

Two treatment approaches — Zytiga (abiraterone acetate) plus prednisolone (AAP) or Taxotere (docetaxel) — provided patients with high-risk prostate cancer similar benefits when added to standard hormone deprivation therapy, according to data recently presented at the European ... Read more

Subscribe to our mailing list

Pin It on Pinterest